248 related articles for article (PubMed ID: 31857133)
1. Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.
Cao F; Liu Z; Sun G
Exp Gerontol; 2020 Feb; 130():110814. PubMed ID: 31857133
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-β induced neurotoxicity.
Zhang H; Liu W; Ge H; Li K
Neurosci Lett; 2021 Jun; 756():135953. PubMed ID: 33979697
[TBL] [Abstract][Full Text] [Related]
3. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ
Ge Y; Song X; Liu J; Liu C; Xu C
Neurochem Res; 2020 Apr; 45(4):741-751. PubMed ID: 31898085
[TBL] [Abstract][Full Text] [Related]
4. Syringin Prevents Aβ
Zhang N; Zhao L; Su Y; Liu X; Zhang F; Gao Y
Neurochem Res; 2021 Mar; 46(3):675-685. PubMed ID: 33471295
[TBL] [Abstract][Full Text] [Related]
5. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation.
Zhang M; Liu Y; Teng P; Yang Q
Neuroimmunomodulation; 2022; 29(3):211-219. PubMed ID: 34749366
[TBL] [Abstract][Full Text] [Related]
7. MiR-193a-3p Promotes Fracture Healing via Targeting PTEN Gene.
Zheng K; Wang Y
Mol Biotechnol; 2021 Jul; 63(7):605-612. PubMed ID: 33813678
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-212 regulates PDCD4 to attenuate Aβ
Wang Y; Chang Q
Biotechnol Lett; 2020 Sep; 42(9):1789-1797. PubMed ID: 32474742
[TBL] [Abstract][Full Text] [Related]
9. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
Wang X; Li M; Hu Y
Physiol Res; 2023 Dec; 72(6):833-841. PubMed ID: 38215068
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
12. Suppression of lncRNA-ATB prevents amyloid-β-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis.
Wang J; Zhou T; Wang T; Wang B
Biomed Pharmacother; 2018 Dec; 108():707-715. PubMed ID: 30248538
[TBL] [Abstract][Full Text] [Related]
13. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
[TBL] [Abstract][Full Text] [Related]
14. Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ
Zhang YY; Bao HL; Dong LX; Liu Y; Zhang GW; An FM
Cell Cycle; 2021 Jan; 20(1):112-125. PubMed ID: 33410377
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
Liu Q; Lei C
Exp Gerontol; 2021 Feb; 144():111187. PubMed ID: 33279668
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-20b-5p aggravates neuronal apoptosis induced by β-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
Tian Z; Dong Q; Wu T; Guo J
Neurosci Lett; 2021 Jan; 742():135542. PubMed ID: 33278507
[TBL] [Abstract][Full Text] [Related]
17. miR-133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role.
Yang Q; Zhao Q; Yin Y
Exp Ther Med; 2019 Oct; 18(4):2711-2718. PubMed ID: 31572518
[TBL] [Abstract][Full Text] [Related]
18. Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease.
Liu L; Liu L; Lu Y; Zhang T; Zhao W
Biomark Med; 2021 Nov; 15(16):1499-1507. PubMed ID: 34668391
[No Abstract] [Full Text] [Related]
19. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
20. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
